🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for amyotrophic lateral sclerosis

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study NCT06649955NA1 site📍 Boston PathMaker Neurosystems Inc. · Tests: Multi-site direct current stimulation (DCS) Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis NCT06877143NA1 site📍 Ulm University of Ulm · Tests: 100% of individual calory requirement, 120% of individual calory requirement Investigation on the Cortical Communication System NCT06207591NA1 site📍 Utrecht UMC Utrecht · Tests: ECoG (electrocorticography) sensing Neurodegenerative Diseases Progression Markers (MARKERS-NDD) NCT06596746n/a1 site📍 Cassino Casa di Cura San Raffaele Cassino · Tests: Observation Spinal Cord Associative Plasticity for ALS NCT06172621NA1 site📍 The Bronx VA Office of Research and Development · Tests: Spinal Cord Associative Plasticity (SCAP), Upper extremity task-oriented exercise A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis NCT07660614Phase 1, Phase 25 sites📍 Lübeck📍 Milan📍 Torino Leal Therapeutics, Inc · Tests: LTX-002, Placebo (aCSF) A Registered Cohort Study on Amyotrophic Lateral Sclerosis NCT04008329n/a1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients NCT05923905Phase 41 site📍 Beijing Peking University Third Hospital · Tests: FB1006, Placebo Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments NCT04816227n/a1 site📍 Paris Institut National de la Santé Et de la Recherche Médicale, … Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders NCT05116943n/a1 site📍 Jacksonville Mayo Clinic Intermuscular Coherence as a Biomarker for ALS NCT05104710n/a4 sites📍 Irvine📍 Miami📍 Boston University of Chicago Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease. NCT07187388NA1 site📍 Davie Nova Southeastern University · Tests: Transcutaneous Electrical Nerve Stimulation to reduce facial pain and improve jaw range of motion in ALS and PLS Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) NCT07357428NA3 sites📍 Sacramento📍 Boston📍 Ann Arbor Paradromics · Tests: Connexus Brain-Computer Interface Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing NCT04394871n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS) NCT06344260Phase 24 sites📍 San Giovanni Rotondo📍 Novara📍 Padua Casa Sollievo della Sofferenza IRCCS · Tests: human Neural Stem Cells (hNSC), Saline (Placebo) Developing New Ways to Detect Respiratory Impairment Early in ALS NCT07844590n/a1 site📍 Philadelphia Thomas Jefferson University Investigation on the Cortical Communication (CortiCom) System NCT03567213NA1 site📍 Baltimore Johns Hopkins University · Tests: Surgical implantation of CortiCom system Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis NCT06318598n/a3 sites📍 Milan📍 Milan📍 Torino Istituto Auxologico Italiano 7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find Non-Invasive Disease Imaging Biomarkers NCT07818772n/a1 site📍 Glasgow NHS Greater Glasgow and Clyde · Tests: MRI Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients NCT03127267Phase 356 sites📍 Birmingham📍 Los Angeles📍 Lexington AB Science · Tests: Masitinib (6.0), Riluzole, Placebo, Masitinib (4.5) Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) NCT07521930NA1 site📍 Baltimore Johns Hopkins University · Tests: INTENT Neural Interface System Invasive Home Ventilation in Denmark NCT07467187n/a1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet Quantification of Hsp90 in the Human Brain NCT07380204NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: [11C]HSP990 PET dosimetry, [11C]HSP990 PET test-retest, [11C]HSP990 simplified scan protocol Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS NCT06598202Phase 1, Phase 21 site📍 Beijing Xuanwu Hospital, Beijing · Tests: exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop, a placebo of exosomes derived f… Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) NCT04454892n/a1 site📍 Beijing Peking University Third Hospital · Tests: Amyotrophic lateral sclerosis High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project NCT06881979NA7 sites📍 Genova📍 Milan📍 Modena Istituti Clinici Scientifici Maugeri SpA · Tests: High-tech rehabilitative treatment, Rehabilitation Identifying Biomarkers in ALS Patients Using Neuronal Derived Extracellular Vesicles NCT07334743n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild EIM Via the Myolex mScan as an ALS Biomarker NCT06491732n/a6 sites📍 Phoenix📍 Boston📍 Boston Beth Israel Deaconess Medical Center · Tests: Electrical Impedance Myography Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone NCT04097158n/a1 site📍 Loma Linda Loma Linda University · Tests: Sample Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy